Cardiorenometabolic Continuum as a Key Cause of Death in Patients With New-Onset Atrial Fibrillation Associated With Covid-19 Pneumonia

Key Points

• To investigate the relationship between the cardiometabolic continuum and mortality in patients with new-onset atrial fibrillation associated with COVID-19 pneumonia.
• Included patients with new-onset atrial fibrillation diagnosed alongside COVID-19 pneumonia.
• Conducted a longitudinal assessment of cardiometabolic factors.
• Analyzed mortality outcomes related to the cardiometabolic continuum.
• Found that patients with both conditions had significantly higher mortality rates.
• Observed an increased risk of death linked to abnormal cardiometabolic parameters.
• Quantified outcomes suggesting the need for targeted interventions.